SN - Smith & Nephew plc
LSE
->
Healthcare
->
Medical Devices
Watford,
United Kingdom
Type: Equity
SN price evolution
SN
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 1 Jul 2023 | 1 Apr 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $302 | $302 | $190 | $190 |
| Short term investments | ||||
| Net receivables | $1333 | $1333 | $1277 | $1277 |
| Inventory | $2395 | $2395 | $2411 | $2411 |
| Total current assets | $4030 | $4030 | $3878 | $3878 |
| Long term investments | $24 | $24 | $35 | $35 |
| Property, plant & equipment | $1470 | $1470 | $1421 | $1421 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $9987 | $9987 | $9844 | $9844 |
| Current liabilities | ||||
| Accounts payable | $1055 | $1055 | $955 | $955 |
| Deferred revenue | ||||
| Short long term debt | $765 | $765 | $407 | $407 |
| Total current liabilities | $2271 | $2271 | $1767 | $1767 |
| Long term debt | $2319 | $2319 | $2633 | $2633 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $4770 | $4770 | $4611 | $4611 |
| Shareholders' equity | ||||
| Retained earnings | $4906 | $4906 | $4963 | $4963 |
| Other shareholder equity | -$385 | -$385 | -$413 | -$413 |
| Total shareholder equity | $5217 | $5217 | $5233 | $5233 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $302 | $350 | $1290 | $1762 |
| Short term investments | ||||
| Net receivables | $1333 | $1178 | $1290 | $1106 |
| Inventory | $2395 | $2205 | $1844 | $1691 |
| Total current assets | $4030 | $3856 | $4424 | $4664 |
| Long term investments | $24 | $58 | $198 | $117 |
| Property, plant & equipment | $1470 | $1455 | $1513 | $1449 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $9987 | $9966 | $10920 | $11012 |
| Current liabilities | ||||
| Accounts payable | $1055 | $1029 | $1096 | $891 |
| Deferred revenue | ||||
| Short long term debt | $765 | $160 | $491 | $337 |
| Total current liabilities | $2271 | $1715 | $2131 | $1688 |
| Long term debt | $2319 | $2712 | $2848 | $3353 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $4770 | $4707 | $5352 | $5733 |
| Shareholders' equity | ||||
| Retained earnings | $4906 | $5026 | $4897 | $4647 |
| Other shareholder equity | -$385 | -$439 | -$328 | |
| Total shareholder equity | $5217 | $5259 | $5568 | $5279 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 1 Jul 2023 | 1 Apr 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1407.5 | $1407.5 | $1367 | $1367 |
| Cost of revenue | $447 | $447 | $418 | $418 |
| Gross Profit | $960.5 | $960.5 | $949 | $949 |
| Operating activities | ||||
| Research & development | $86.5 | $86.5 | $83 | $83 |
| Selling, general & administrative | $799 | $799 | $728.5 | $728.5 |
| Total operating expenses | $1332.5 | $1332.5 | $1229.5 | $1229.5 |
| Operating income | $75 | $75 | $137.5 | $137.5 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$6 | -$6 | $19.5 | $19.5 |
| Interest expense | -$35 | -$35 | -$31 | -$31 |
| Net income | ||||
| Net income | $45.5 | $45.5 | $86 | $86 |
| Income (for common shares) | $45.5 | $45.5 | $86 | $86 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5549 | $5215 | $5212 | $4560 |
| Cost of revenue | $1730 | $1540 | $1543 | $1375 |
| Gross Profit | $3819 | $3675 | $3669 | $3185 |
| Operating activities | ||||
| Research & development | $339 | $345 | $356 | $279 |
| Selling, general & administrative | $3055 | $2880 | $2377 | $2160 |
| Total operating expenses | $5124 | $4765 | $4544 | $4265 |
| Operating income | $425 | $668 | $295 | |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $27 | $12 | $62 | -$202 |
| Interest expense | -$132 | -$80 | ||
| Net income | ||||
| Net income | $263 | $223 | $524 | $448 |
| Income (for common shares) | $263 | $223 | $524 | $448 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 1 Jul 2023 | 1 Apr 2023 |
|---|---|---|---|---|
| Net income | $45.5 | $45.5 | $86 | $86 |
| Operating activities | ||||
| Depreciation | $80 | $80 | $97.5 | $97.5 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $247.5 | $247.5 | $56.5 | $56.5 |
| Investing activities | ||||
| Capital expenditures | -$130 | -$130 | -$83.5 | -$83.5 |
| Investments | ||||
| Total cash flows from investing | -$133 | -$133 | -$91 | -$91 |
| Financing activities | ||||
| Dividends paid | -$63 | -$63 | -$100.5 | -$100.5 |
| Sale and purchase of stock | -$0.5 | -$0.5 | $0.5 | $0.5 |
| Net borrowings | $2.5 | $2.5 | $59 | $59 |
| Total cash flows from financing | -$57 | -$57 | -$43 | -$43 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $58.5 | $58.5 | -$80.5 | -$80.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $263 | $223 | $586 | $246 |
| Operating activities | ||||
| Depreciation | $355 | $319 | $581 | $562 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $608 | $468 | $877 | $935 |
| Investing activities | ||||
| Capital expenditures | -$427 | -$358 | -$408 | -$443 |
| Investments | ||||
| Total cash flows from investing | -$448 | -$472 | -$691 | -$606 |
| Financing activities | ||||
| Dividends paid | -$327 | -$327 | -$329 | -$328 |
| Sale and purchase of stock | -$152 | $14 | -$5 | |
| Net borrowings | $123 | -$450 | -$326 | $1490 |
| Total cash flows from financing | -$200 | -$926 | -$645 | $1164 |
| Effect of exchange rate | -$7 | $1 | ||
| Change in cash and equivalents | -$44 | -$941 | -$466 | $1494 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $5.55B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $263.00M |
| Revenue Q/Q | 7.65% |
| Revenue Y/Y | 6.40% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 2.65% |
| ROE | 5.03% |
| Debt/Equity | 0.91 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.77 |
| Quick ratio | 0.72 |